PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2014
CASE
AUTH/2727/8/14 Pierre Fabre

Pierre Fabre found in breach over β€˜under-dosing’ Navelbine Oral letter to oncology pharmacists (AUTH/2727/8/14)

A β€˜safety’ letter about Navelbine Oral dosing was ruled promotional. Missing prescribing info and AE reporting, an unqualified indication, and misleading/unsupported efficacy-survival…

2014
CASE
AUTH/2713/5/14 Eli Lilly ⭐ Case of the Week

AUTH/2713/5/14: Chief Pharmacist v Eli Lilly β€” Strattera nurse speaker engagement (No breach)

An NHS chief pharmacist alleged a Strattera nurse speaker contract looked like inducement/seeding research and queried disclosure. PMCPA found misunderstanding from wording…

2013
CASE
AUTH/2665/11/13 Genzyme

AUTH/2665/11/13: Genzyme (Sanofi) – clinical trial disclosure delays for Mozobil; no breach for Renvela (timing pre-Code)

Public complaint about clinical trial transparency data. Panel found delayed disclosure for one UK-involved Mozobil trial (breach Clauses 9.1, 21.3). Renvela issues…

2008
CASE
AUTH/2084/1/08 Novartis Pharmaceuticals UK

AUTH/2084/1/08: Anonymous v Novartis β€” hospitality at educational meeting (no breach)

Anonymous complaint alleged excessive hospitality and poor rep conduct at a Novartis-sponsored restaurant meeting. Panel said costs/drinks were at the outer limits…

2015
CASE
AUTH/2815/12/15 Piramal Healthcare UK

AUTH/2815/12/15: AbbVie v Piramal β€” Sevoflurane β€œdrop test” leaflet treated as promotional; missing cost, AE statement and date

A sevoflurane packaging β€œdrop test” leaflet was ruled promotional. It omitted the medicine’s cost, the mandatory adverse event reporting statement and the…

2016
CASE
AUTH/2853/6/16 GlaxoSmithKline

AUTH/2853/6/16: Anonymous v GlaxoSmithKline (Telegraph Online malaria vaccine corporate ad) – No breach

Anonymous complaint alleged GSK promoted an unlicensed malaria vaccine to the public via a Telegraph Online ad. PMCPA ruled the 30-second video…

2016
CASE
AUTH/2919/12/16 Merck Sharp & Dohme ⭐ Case of the Week

AUTH/2919/12/16: Anonymous (non-contactable) v Merck Sharp & Dohme β€” no breach (representative conduct allegation)

Anonymous GP alleged an MSD representative brought her daughter to meetings. MSD found no record of any complaint. Panel said allegation not…

2016
CASE
AUTH/2865/8/16 Sanofi

AUTH/2865/8/16: Anonymous (non-contactable) v Sanofi β€” MEGS nurse advisor service (No breach)

Anonymous complaint alleged industry-funded audits/workshops and coercive behaviour via a nurse-led consultancy. Panel found no evidence against Sanofi; its MEGS nurse advisor…

2016
CASE
AUTH/2920/12/16 UCB Pharma

UCB: internal β€œtake-home naloxone” poster deemed briefing material and breached high standards (AUTH/2920/12/16)

Anonymous ex-rep alleged off-licence promotion of Naloxone Minijet. Panel found no off-licence breach, but ruled an internal conference poster functioned as rep…

2017
CASE
AUTH/2941/2/17 Merck Sharp & Dohme

AUTH/2941/2/17: Health professional consultant v Merck Sharp & Dohme (webcast invitation) – No breach

MSD sent a third-party email invite (via Pulse) to a cardiovascular webcast labelled promotional but with no product named and no prescribing…

2017
CASE
AUTH/2953/4/17 Dr Falk Pharma

AUTH/2953/4/17: Dr Falk journal ad for Salofalk Granules – β€œstep change” headline ruled misleading

A competitor challenged a Salofalk Granules journal ad. The PMCPA ruled the β€œstep change… Now that’s progress” headline misleading, exaggerated and unsubstantiated…

2017
CASE
AUTH/2951/4/17 Sanofi ⭐ Case of the Week

Sanofi breached ABPI Code over Toujeo β€œLatest Data” app implying hypoglycaemia benefit from clamp-study PK/PD data (AUTH/2951/4/17)

Toujeo iPad β€œLatest Data” app design and training encouraged linking clamp-study PK/PD variability data to reduced hypoglycaemia. Panel found the material misleading…

2018
CASE
AUTH/3036/4/18 Concordia International Rx

AUTH/3036/4/18: Health professional v Concordia (Morphgesic SR journal ad) – No breach

A health professional alleged a Morphgesic SR ad used outdated prescribing information (May 2013). The Panel found the PI had a Dec…

2007
CASE
AUTH/1980/3/07 Sanofi

Sanofi Pasteur MSD: Gardasil scrutiny after Guardian articlesβ€”journalist payments and sponsorship disclosure (AUTH/1980/3/07, AUTH/1983/3/07)

Guardian articles criticised Gardasil promotion and a Paris cervical cancer summit. Panel found breaches for inadequate upfront sponsorship disclosure on invitations and…

2007
CASE
AUTH/2056/10/07 Novo Nordisk

Eli Lilly v Novo Nordisk: Levemir ad implied weight loss via β€œChanging Figures” strapline and imagery (AUTH/2056/10/07)

A Levemir journal ad showing overweight women in a pool with the strapline β€œLevemir is changing figures” was ruled misleading/ambiguous, implying weight…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training